Clincosm LogoSign in Get a demo

aml

Showing NaN - NaN of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)

Not yet recruiting
  • Hematologic Malignancy
  • +10 more
  • Los Angeles, California
  • +28 more
Jul 26, 2022

AML, Advanced MDS, ALL Trial in Chicago, New York (OTS167IV)

Terminated
  • AML
  • +4 more
  • Chicago, Illinois
  • +1 more
Nov 15, 2021

MDS, CMML, AML Trial in Canada, United States (SGI-110)

Completed
  • MDS
  • +2 more
  • Scottsdale, Arizona
  • +15 more
Apr 16, 2021

AML Trial in Worldwide (Quizartinib, Salvage Chemotherapy)

Completed
Has Results
  • AML
  • Duarte, California
  • +130 more
Feb 2, 2021

Advanced and Selected Solid Tumors, AML, High Risk and Very High Risk MDS Trial in Worldwide (BYL719, MEK162)

Completed
  • Advanced and Selected Solid Tumors
  • +2 more
  • La Jolla, California
  • +15 more
Sep 29, 2017

AML, ALL, Blast Crisis Trial in United States (TG02 citrate, Carfilzomib, Dexamethasone)

Completed
  • AML
  • +4 more
  • TG02 citrate
  • +2 more
  • Denver, Colorado
  • +8 more
May 5, 2016

AML Trial in Canada, United States (Obatoclax)

Completed
  • AML
  • Chicago, Illinois
  • +12 more
Aug 16, 2013

Acute Myeloid Leukemia, AML Trial in Canada, Netherlands, United States (Tosedostat)

Completed
  • Acute Myeloid Leukemia
  • AML
  • Los Angeles, California
  • +20 more
Jun 27, 2012

Acute Myeloid Leukemia, AML Trial in United States (XL999)

Terminated
  • Acute Myeloid Leukemia
  • AML
  • Alhambra, California
  • +6 more
Feb 18, 2010